These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6428321)

  • 1. [Joint clinical Phase II study of SF-SP].
    Sato T; Sato H; Hanatani Y
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1210-7. PubMed ID: 6428321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of tegafur encapsulated with slow-releasing granules (SF-SP) for patients with cancer of the digestive organs].
    Kameda C; Tanaka T; Shiomi M; Saka M; Katsu K; Itoh S
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2526-30. PubMed ID: 6439120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cooperative phase II study of releasing tegafur (SF-SP) against advanced digestive cancers].
    Ibayashi J
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1414-9. PubMed ID: 6430244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical trial on the effect of tegafur (SF-SP)].
    Futatsuki K; Shimada S; Kanda Y; Ishibashi I; Sendai H; Akazawa S; Hattori M
    Gan To Kagaku Ryoho; 1984 May; 11(5):1112-5. PubMed ID: 6326685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cooperative phase II study of spansule tegafur (SF-SP)].
    Taguchi T
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):319-26. PubMed ID: 6421250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative clinical study of SF-SP therapy and SF-SP plus BH-AC therapy in gastrointestinal cancer. Tokyo Cancer Chemotherapy Cooperative Study Group].
    Izumi T; Yoshida M; Kamaro T; Sato H
    Gan To Kagaku Ryoho; 1986 Oct; 13(11):3215-20. PubMed ID: 3096218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Phase II study of sustained released granules of tegafur (SF-SP) on inoperable or recurrent gastric cancer].
    Sakata Y; Yoshida Y
    Gan To Kagaku Ryoho; 1985 May; 12(5):1068-72. PubMed ID: 3922308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of chemotherapy in the field of internal medicine--clinical experience with SF-SP].
    Irie K; Yasutake K; Imamura Y; Yoshimura Y; Nakamura T; Yoshida M; Fujisawa T; Nishimura S; Mizogami H; Sawada Y
    Gan To Kagaku Ryoho; 1986 May; 13(5):1893-6. PubMed ID: 3085595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phase II study of 590-S (1-phthalidyl-5-fluorouracil) in patients with gastrointestinal cancer. Tokyo Cancer Chemotherapy Cooperative Group].
    Nakatsu T; Takahashi H; Furue H
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3114-8. PubMed ID: 3674897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative study on two different types of tegafur for recurrent breast cancer].
    Taguchi T
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):312-8. PubMed ID: 6421249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New oral anticancer drug, TS-1 (S-1)--from bench to clinic].
    Shirasaka T; Tsukuda M; Inuyama Y; Taguchi T
    Gan To Kagaku Ryoho; 2001 Jun; 28(6):855-64. PubMed ID: 11432358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A phase II study of ranomustine (MCNU) tablets in patients with gastrointestinal cancer--by cooperative study group].
    Taguchi T
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2420-6. PubMed ID: 6497400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phase II study of a new fluorinated pyrimidine, ethyl (+/-)-t-6-butoxy-5-fluoro-2, 4-dioxohexahydropyrimidine-r-5-carboxylate (TAC-278)].
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1821-6. PubMed ID: 7184376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biochemical modulation of 5-FU--effect of low dose CDDP].
    Hirata K; Yamamitsu S; Tsuji A; Shirasaka T; Mukaiya M; Oikawa I; Kimura H; Sasaki K; Denno R
    Gan To Kagaku Ryoho; 1999 Mar; 26(4):467-75. PubMed ID: 10097743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical evaluation of combination chemotherapy of aclacinomycin A (ACM) and 5-fluorouracil (5-FU) for advanced carcinoma of gastrointestinal tract].
    Kikuchi K
    Gan To Kagaku Ryoho; 1982 Apr; 9(4):716-21. PubMed ID: 6764110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A phase II study of 590-S (1-phthalidyl-5-fluorouracil) in patients with breast cancer--multi-center cooperative study--Cooperative Study Group of 590-S in Breast Cancer].
    Taguchi T; Terasawa T
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):467-71. PubMed ID: 3813575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of orally and rectally administered Tegafur in liver metastases from gastric carcinoma.
    Reyes JM; Okazaki N; Yoshino M; Yoshida T
    Jpn J Clin Oncol; 1984 Mar; 14(1):41-7. PubMed ID: 6423866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Conceptual changes in cancer chemotherapy--biochemical modulation of 5-FU].
    Shirasaka T; Yamamitsu S; Tsuji A; Terashima M; Hirata K
    Gan To Kagaku Ryoho; 2000 Jun; 27(6):832-45. PubMed ID: 10897209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The case studies on oral administration of tegafur encapsulated with slow releasing granule (SF-SP) for three rectal patients].
    Sato T; Sekine S; Katsumi S; Mukae S; Watanabe S; Furukawa R; Watanabe I; Endo S
    Gan To Kagaku Ryoho; 1984 May; 11(5):1107-11. PubMed ID: 6426404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of tegafur suppository and glutathione in patients with gastric and colonic cancer with special reference to the histopathological anticancer effect].
    Kitajima M; Ikeda Y; Kiuchi T; Okada N; Fukuzumi N; Kaga F
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3131-9. PubMed ID: 3118814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.